Keyphrases
Glutamate Dehydrogenase
100%
GluD2
100%
Parkinson's Disease
75%
Estrogen
75%
Deregulation
50%
Glutamate
50%
Hemizygous
50%
Krebs Cycle
50%
Female Heterozygotes
50%
Neuroactive Steroids
50%
Genotype
25%
Neurologic Disorders
25%
Primates
25%
North America
25%
Therapeutic Intervention
25%
Neurological Impairment
25%
Disease Onset
25%
Testicle
25%
Haloperidol
25%
Evolutionary
25%
Astrocytes
25%
Catalytic Properties
25%
Lactate
25%
Selective Expression
25%
Disease Groups
25%
X-linked
25%
Isoenzymes
25%
α-ketoglutarate (α-KG)
25%
Cortical Astrocytes
25%
Glutamate Metabolism
25%
Glutamatergic Transmission
25%
Greek
25%
Sertoli Cells
25%
Cell Degeneration
25%
Regulatory Domain
25%
Metabolic Recycling
25%
Recycling Process
25%
GLUD1
25%
Glutamate Oxidation
25%
GLUD1 Gene
25%
Enhanced Catalytic Activity
25%
Retroposition
25%
Regulatory Profiles
25%
Perphenazine
25%
Biochemistry, Genetics and Molecular Biology
Guanosine Triphosphate
100%
Glutamate Dehydrogenase
100%
Glutamic Acid
100%
Enzyme
75%
Astrocyte
50%
Citric Acid Cycle
50%
Krebs Cycle
50%
Metabolic Pathway
25%
Wild Type
25%
Adenosine Triphosphate
25%
Glutamatergic
25%
Isoenzyme
25%
Sertoli Cell
25%
Typical Antipsychotic
25%
Cell Degeneration
25%
Neuroactive Steroid
25%
Perphenazine
25%
Enzymatic Activity
25%
Haloperidol
25%
Neuroscience
Glutamic Acid
100%
Guanosine Triphosphate
100%
Glutamate Dehydrogenase
100%
Parkinson's Disease
75%
Astrocyte
50%
Citric Acid Cycle
50%
Neurodegenerative Disorder
25%
Metabolic Pathway
25%
Typical Antipsychotic
25%
Adenosine Triphosphate
25%
Sertoli Cell
25%
Cell Degeneration
25%
Neuroactive Steroid
25%
Perphenazine
25%
Isoenzyme
25%
Haloperidol
25%